enVVeno Medical Corporation Financial Statements — NVNOW

Income Statement	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Sales/Revenue/Turnover	- -	1	- -	- -	- -	- -	- -	- -	- -
+ Sales & Services Revenue	- -	1	- -	- -	- -	- -	- -	- -	- -
- Cost of Revenue	- -	1	- -	- -	- -	- -	- -	- -	- -
+ Cost of Goods & Services	- -	1	- -	- -	- -	- -	- -	- -	- -
Gross Profit	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Operating Expenses	1	5	6	8	7	9	17	25	25
+ Selling, General & Admin	1	5	5	6	5	5	11	15	12
+ Research & Development	- -	- -	1	1	2	4	6	10	14
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-1	-5	-6	-8	-7	-9	-17	-25	-25
- Non-Operating (Income) Loss	- -	1	2	6	1	- -	- -	- -	-2
+ Interest Expense, Net	- -	- -	2	7	- -	- -	- -	- -	- -
+ Interest Expense	- -	- -	2	7	- -	- -	- -	- -	- -
- Interest Income	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	1	- -	-1	1	- -	- -	- -	-2
Pretax Income	-1	-6	-8	-13	-8	-9	-17	-25	-24
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-1	-6	-8	-13	-8	-9	-17	-25	-24
- Net Extraordinary Losses (Gains)	- -	-2	- -	- -	- -	- -	- -	- -	- -
+ Discontinued Operations	- -	2	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	-4	- -	- -	- -	- -	- -	- -	- -
Income (Loss) Incl. MI	-2	-3	-8	-13	-8	-9	-17	-25	-24
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	-2	-3	-8	-13	-8	-9	-17	-25	-24
- Preferred Dividends	- -	- -	- -	3	- -	1	- -	- -	- -
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income Avail to Common, GAAP	-2	-4	-8	-16	-8	-10	-17	-25	-24
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA	-1	-5	-6	-7	-7	-9	-16	-24	-25
EBITDA Margin (%)	- -	-573.6	-1,412.91	-3,967.65	-21,412.24	- -	- -	- -	- -
EBITA	-1	-5	-6	-8	-7	-9	-17	-25	-25
EBIT	-1	-5	-6	-8	-7	-9	-17	-25	-25
Gross Margin (%)	- -	-3.1	0.58	100	100	- -	- -	- -	- -
Operating Margin (%)	- -	-592.84	-1,445.89	-4,039.17	-22,681.85	- -	- -	- -	- -
Profit Margin (%)	- -	-431.03	-1,845.83	-6,991.46	-24,406.74	- -	- -	- -	- -
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	1	1

Balance Sheet	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
Total Current Assets	2	- -	- -	3	1	10	55	39	47
+ Cash, Cash Equivalents & STI	2	- -	- -	3	1	9	55	39	46
+ Cash & Cash Equivalents	2	- -	- -	3	1	9	55	5	4
+ ST Investments	- -	- -	- -	- -	- -	- -	- -	34	43
+ Accounts & Notes Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accounts Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	1
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	1	1	2	1	2	1	3	2	2
+ Property, Plant & Equip, Net	- -	- -	- -	- -	1	1	3	2	2
+ Property, Plant & Equip	- -	- -	- -	- -	2	1	3	3	3
- Accumulated Depreciation	- -	- -	- -	- -	- -	- -	1	1	1
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Assets	1	1	2	1	1	- -	- -	- -	- -
+ Total Intangible Assets	1	1	1	1	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	1	1	1	1	- -	- -	- -	- -	- -
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	1	- -	1	- -	- -	- -	- -
Total Assets	3	2	2	4	3	11	58	42	49
+ Payables & Accruals	1	1	2	1	1	2	1	1	- -
+ Accounts Payable	1	1	1	1	1	1	1	1	- -
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Payables & Accruals	- -	- -	- -	- -	- -	1	- -	- -	- -
+ ST Debt	2	1	3	- -	- -	1	- -	- -	- -
+ ST Borrowings	2	1	3	- -	- -	- -	- -	- -	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	2	1	4	- -	- -	1	1	1	1
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	2	1	4	- -	- -	- -	1	1	1
Total Current Liabilities	5	2	8	2	2	3	2	2	1
+ LT Debt	- -	- -	- -	- -	1	- -	2	1	1
+ LT Borrowings	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Finance Leases	- -	- -	- -	- -	1	- -	2	1	1
+ Other LT Liabilities	2	4	- -	- -	- -	- -	- -	- -	- -
+ Accrued Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	2	4	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	2	4	- -	- -	1	- -	2	1	1
Total Liabilities	6	6	8	2	2	3	3	3	2
+ Preferred Equity and Hybrid Capital	- -	- -	5	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	21	24	24	51	57	72	136	145	176
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Additional Paid in Capital	21	24	24	51	57	72	136	145	176
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-24	-28	-36	-49	-56	-65	-82	-107	-130
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	-4	-4	-6	2	1	7	54	39	46
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	-4	-4	-6	2	1	7	54	39	46
Total Liabilities & Equity	3	2	2	4	3	11	58	42	49
Shares Outstanding	- -	- -	- -	- -	1	3	9	9	13
Capital Leases - Total	- -	- -	- -	- -	1	1	2	2	1
Net Debt	- -	1	3	-3	-1	-9	-55	-5	-4
Net Debt to Equity	-6.87	-13.66	-42.64	-134.58	-132.05	-127.11	-100.6	-11.76	-7.84
Tangible Common Equity Ratio	-226.61	-991.02	-1,107.2	47.36	28.83	67.36	94.29	92.96	94.99
Current Ratio	0.38	0.19	0.02	1.86	0.76	3	34.84	25.78	34.23
Cash Conversion Cycle	- -	-209.02	-1,041.58	- -	- -	- -	- -	- -	- -
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y
+ Net Income	-2	-3	-8	-13	-8	-9	-17	-25	-24
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -	- -	1	1
+ Non-Cash Items	- -	- -	2	7	1	- -	5	9	5
+ Stock-Based Compensation	- -	2	1	2	1	1	6	9	5
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Asset Impairment Charge	- -	- -	- -	- -	1	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	-2	1	5	- -	- -	-1	- -	- -
+ Chg in Non-Cash Work Cap	-1	- -	1	-1	- -	1	-1	- -	-1
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inc (Dec) in Accts Payable	- -	- -	1	-1	- -	1	-1	- -	- -
+ Inc (Dec) in Other	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-2	-3	-4	-6	-6	-8	-12	-16	-19
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	- -	- -	- -	- -	- -	- -	- -	-34	-8
+ Dec in LT Investment	- -	- -	- -	- -	- -	- -	- -	14	49
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -	- -	-48	-57
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	- -	- -	- -	- -	- -	- -	- -	-35	-8
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	1	- -	3	2	- -	- -	- -	- -	- -
+ Cash From Debt	1	- -	3	3	- -	- -	- -	- -	- -
+ Repayments of Debt	-1	- -	- -	-1	- -	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	8	6	10	57	- -	26
+ Increase in Capital Stock	- -	- -	- -	8	6	10	57	- -	26
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Financing Activities	3	2	1	-1	- -	4	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	4	2	4	9	6	15	58	- -	26
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	2	-2	- -	3	-1	7	45	-50	-1
Capital Expenditures	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA	-1	-5	-6	-7	-7	-9	-16	-24	-25
EBITDA Margin (%)	- -	-573.6	-1,412.91	-3,967.65	-21,412.24	- -	- -	- -	- -
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow	-2	-4	-4	-6	-6	-8	-12	-16	-19
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	- -	-4	4	-13	-6	-8	-12	-16	-19
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow to Net Income	1.26	1.01	0.54	0.49	0.77	0.84	0.72	0.63	0.8

enVVeno Medical Corporation

Income Statement

Balance Sheet

Cash Flow Statement